SCHEMBL6999323

SCHEMBL6999323

CC1(C)OC(c2ccc(S(N)(=O)=O)cc2)=C(c2cccc(-c3ccccc3)c2)C1=O

nearest known ligand 0.77

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 15/20 0.54
CA9 Q16790 12/20 0.54
CA12 O43570 8/20 0.54
CA1 P00915 14/20 0.49
PTGS2 P35354 4/20 0.47
MEN1 O00255 1/20 0.41
POLB P06746 1/20 0.41
KMT2A Q03164 1/20 0.41
MAOA P21397 1/20 0.41
MAOB P27338 1/20 0.41
MT-CO2 P00403 1/20 0.41
LMNA P02545 1/20 0.41
CA3 P07451 1/20 0.41
ADRB2 P07550 1/20 0.41
ADRB1 P08588 1/20 0.41
CYP3A4 P08684 1/20 0.41
ADORA3 P0DMS8 1/20 0.41
CHRM1 P11229 1/20 0.41
ADRA2B P18089 1/20 0.41
CA4 P22748 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7002002 0.91 PTGS2 (0.56) CA2CA9CA12CA1PTGS2
SCHEMBL6999849 0.89 CA2 (0.53) CA2CA9CA12CA1PTGS2
SCHEMBL7001251 0.88 CA2 (0.56) CA2CA9CA12CA1PTGS2
SCHEMBL3232569 0.87 CA2 (0.51) CA2CA9CA12CA1PTGS2
Polmacoxib SCHEMBL3233093 0.87 PTGS2 (0.55) CA2CA9CA12CA1PTGS2
Polmacoxib SCHEMBL29351757 0.87 PTGS2 (0.55) CA2CA9CA12CA1PTGS2
SCHEMBL6995958 0.85 CA2 (0.56) CA2CA9CA12CA1PTGS2
SCHEMBL6999759 0.85 PTGS2 (0.44) CA2CA9CA12CA1PTGS2
SCHEMBL7000627 0.85 CA2 (0.49) CA2CA9CA12CA1PTGS2
SCHEMBL6996285 0.85 CA2 (0.42) CA2CA9CA12CA1PTGS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1109799-B1 4,5-DIARYL-3(2H)-FURANONE DERIVATIVES AS CYCLOOXYGENASE-2 INHIBITORS PACIFIC CORP (KR) 2003-12-17 EP claimed
US-6492416-B1 TREATING INFLAMMATION AND ASSOCIATED DISORDERS PACIFIC CORPORATION (KR) 2002-12-10 US claimed
EP-1109799-A1 4,5-DIARYL-3(2H)-FURANONE DERIVATIVES AS CYCLOOXYGENASE-2 INHIBITORS PACIFIC CORPORATION (KR) 2001-06-27 EP claimed
WO-2000061571-A1 4,5-DIARYL-3(2H)-FURANONE DERIVATIVES AS CYCLOOXYGENASE-2 INHIBITORS PACIFIC CORPORATION (KR) 2000-10-19 WO claimed
EP-1109799-B1 4,5-DIARYL-3(2H)-FURANONE DERIVATIVES AS CYCLOOXYGENASE-2 INHIBITORS PACIFIC CORP (KR) 2003-12-17 EP disclosed
US-6492416-B1 TREATING INFLAMMATION AND ASSOCIATED DISORDERS PACIFIC CORPORATION (KR) 2002-12-10 US disclosed
EP-1109799-A1 4,5-DIARYL-3(2H)-FURANONE DERIVATIVES AS CYCLOOXYGENASE-2 INHIBITORS PACIFIC CORPORATION (KR) 2001-06-27 EP disclosed
WO-2000061571-A1 4,5-DIARYL-3(2H)-FURANONE DERIVATIVES AS CYCLOOXYGENASE-2 INHIBITORS PACIFIC CORPORATION (KR) 2000-10-19 WO disclosed